For Research Purposes Only · Not For Human Consumption
Skin / Anti-Ageing Blend
High-payload copper peptide + repair blend. KPV + GHK-Cu + BPC-157 + TB-500 co-lyophilised for advanced collagen and connective-tissue research.
Vial size
Quantity
£69.99
In stockInc. VAT · Free UK shipping on this order
SSL encrypted · CoA published for this lot
Certificate of Analysis
KLOW 80mg
The CoA you download is the exact certificate produced for this lot — no edits.
Storage & handling
Keep it stable, keep it sterile
KLOW is UK Peptides' proprietary high-payload research blend combining KPV, GHK-Cu, BPC-157 and TB-500 in a single co-lyophilised vial. Designed to support extended in-vitro protocols investigating combined anti-inflammatory, copper-peptide collagen and connective-tissue repair pathways. Each component independently HPLC-verified to ≥98%.
KLOW is UK Peptides' proprietary quad-peptide co-lyophilised research blend combining KPV (Lys-Pro-Val), GHK-Cu (copper tripeptide-1), BPC-157 (pentadecapeptide) and TB-500 (Thymosin Beta-4 fragment) in a single 80mg vial. Designed for research groups investigating combined anti-inflammatory, copper-peptide collagen and connective-tissue repair pathways. Every component is independently HPLC-verified to ≥98% purity with a batch-matched Certificate of Analysis.
Store the lyophilised vial at -20°C, sealed and protected from light — copper peptide components are particularly light-sensitive. Refrigerate the reconstituted solution at 2–8°C and use within 14 days.
For longer storage, aliquot and freeze at -20°C. Do not refreeze thawed material.
The KLOW Certificate of Analysis reports HPLC-UV purity and mass-spectrometry identity for each of the four component peptides separately. Every batch is signed off by an accredited independent laboratory, with copper content on the GHK-Cu component verified independently. The signed PDF CoA is supplied with every order.
Co-lyophilised multi-peptide blends demand more sophisticated HPLC method development than single-peptide vials — under-dosing or component substitution on the grey market is common. UK Peptides addresses this with four-component independent verification on every KLOW lot, UK stock, same-day Manchester dispatch and full lot traceability visible on this product page.
The science, in depth
Mechanism, the published evidence and handling detail for KLOW are covered in full in our research library — 6 referenced articles rather than a summary on a product page.
KLOW is a proprietary co-lyophilised research blend of four separately-studied peptides: KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH), GHK-Cu (copper tripeptide-1), BPC-157 (a synthetic pentadecapeptide) and TB-500 (a fragment of Thymosin Beta-4). Each component is HPLC-verified independently.
Regulatory & compliance notice
This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.
Last reviewed 22 July 2026.
Peer-referenced articles from our research library covering mechanism, evidence and handling.
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.
Legal notice
This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.
KLOW 80mg
£69.99
